---
title: "Lonza Group Ltd (LONN) Gets a Buy from Barclays"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290403921.md"
description: "Barclays analyst Charles Pitman CFA maintained a Buy rating on Lonza Group Ltd (LONN) with a CHF670 price target. Lonza holds a Strong Buy consensus among analysts, with an average price target of CHF664. Pitman is recognized as a 5-star analyst with a 13.7% average return."
datetime: "2026-06-22T07:56:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290403921.md)
  - [en](https://longbridge.com/en/news/290403921.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290403921.md)
generator: "portal-rs"
---

# Lonza Group Ltd (LONN) Gets a Buy from Barclays

In a report released today, Charles Pitman CFA from Barclays maintained a Buy rating on Lonza Group Ltd, with a price target of CHF670.00.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Pitman CFA is a 5-star analyst with an average return of 13.7% and a 62.50% success rate.

Lonza Group Ltd has an analyst consensus of Strong Buy, with a price target consensus of CHF664.00.

### Related Stocks

- [LZAGY.US](https://longbridge.com/en/quote/LZAGY.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [Lonza enlists returning exec for new commercial chief post](https://longbridge.com/en/news/297553743.md)
- [CLSA: Global Pharma Supply Chain Enters Decade-long Restructuring; Prefers Platform Leaders Including Thermo Fisher Scientific Inc , WUXI APPTEC](https://longbridge.com/en/news/297863665.md)
- [RBC Capital Remains a Hold on Sandoz Group Ltd (SDZXF)](https://longbridge.com/en/news/298004740.md)
- [Iconovo enters strategic collaboration agreement with Lonza on spray-dried inhaled formulations](https://longbridge.com/en/news/296445004.md)
- [Springer Nature names Patric Somlo CFO, succeeding Alexandra Dambeck](https://longbridge.com/en/news/297673233.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**